Compounds > bicalutamide

bicalutamide and Cancer of Salivary Gland

bicalutamide has been researched along with Cancer of Salivary Gland in 9 studies

Research

Studies (9)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's7 (77.78)24.3611
2020's2 (22.22)2.80

Authors

AuthorsStudies
Jeong, ISD; Moyers, J; Thinn, MM; Thung, I1
Athikari, N; Datar, R; Khandare, H; Kumar, P; Limaye, S; Madre, C; Peshattiwar, V; Pragya, R; Sambath, J; Sheth, H; Shreenivas, A1
Fushimi, C; Hirai, H; Hoshino, E; Kamata, S; Kawakita, D; Masubuchi, T; Matsuki, T; Miura, K; Nagao, T; Ojiri, H; Saotome, T; Tada, Y; Takahashi, H1
Gourd, E1
Akaev, I; Brennan, PA; Chhikara, R; Dabab, N; Fonseca, F; Gomez, RS; Rahimi, S; Rigby, E; Yeoh, CC1
Iganej, S; Soper, MS; Thompson, LD1
Bossi, P; Civelli, E; Cortelazzi, B; Imbimbo, M; Licitra, L; Locati, LD; Perrone, F; Pilotti, S; Potepan, P; Quattrone, P; Rinaldi, G1
Bergamini, C; Bossi, P; Civelli, E; Cortelazzi, B; Dagrada, G; Fallai, C; Licitra, L; Lo Vullo, S; Locati, LD; Perrone, F; Pilotti, S; Potepan, P; Quattrone, P1
Jaspers, HC; Mattijssen, V; Schoffelen, R; Slootweg, PJ; van der Graaf, WT; van Herpen, CM; Verbist, BM1

Trials

1 trial(s) available for bicalutamide and Cancer of Salivary Gland

ArticleYear
A prospective phase II study of combined androgen blockade in patients with androgen receptor-positive metastatic or locally advanced unresectable salivary gland carcinoma.
    Annals of oncology : official journal of the European Society for Medical Oncology, 2018, 04-01, Volume: 29, Issue:4

    Topics: Aged; Aged, 80 and over; Androgen Antagonists; Anilides; Disease-Free Survival; Female; Humans; Leuprolide; Male; Middle Aged; Neoplasm Metastasis; Nitriles; Prospective Studies; Receptors, Androgen; Salivary Gland Neoplasms; Tosyl Compounds; Treatment Outcome

2018

Other Studies

8 other study(ies) available for bicalutamide and Cancer of Salivary Gland

ArticleYear
Combination Chemohormonal Therapy in Metastatic Salivary Duct Carcinoma.
    The American journal of case reports, 2020, Jun-30, Volume: 21

    Topics: Aged; Anilides; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma; Humans; Leuprolide; Male; Nitriles; Paclitaxel; Salivary Ducts; Salivary Gland Neoplasms; Tosyl Compounds

2020
Excellent Response With Alpelisib and Bicalutamide for Advanced Salivary Duct Carcinoma With PIK3CA Mutation and High Androgen Receptor Expression-A Case Report.
    JCO precision oncology, 2021, Volume: 5

    Topics: Anilides; Antineoplastic Agents; Class I Phosphatidylinositol 3-Kinases; Humans; Male; Middle Aged; Mutation; Neoplasm Staging; Nitriles; Receptors, Androgen; Salivary Ducts; Salivary Gland Neoplasms; Thiazoles; Tosyl Compounds

2021
Combined androgen blockade for salivary gland carcinoma.
    The Lancet. Oncology, 2018, Volume: 19, Issue:1

    Topics: Androgen Antagonists; Anilides; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Clinical Trials, Phase II as Topic; Disease-Free Survival; Humans; Leuprolide; Nitriles; Receptors, Androgen; Salivary Gland Neoplasms; Signal Transduction; Tosyl Compounds; Treatment Outcome

2018
Androgen receptor in salivary gland carcinoma: A review of an old marker as a possible new target.
    Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology, 2018, Volume: 47, Issue:7

    Topics: Adenocarcinoma; Administration, Oral; Androgen Antagonists; Androstenes; Anilides; Antineoplastic Agents; Benzamides; Biomarkers, Tumor; Carcinoma, Adenoid Cystic; Carcinoma, Mucoepidermoid; Female; Humans; Male; Molecular Targeted Therapy; Nitriles; Phenylthiohydantoin; Receptors, Androgen; Salivary Ducts; Salivary Gland Neoplasms; Tosyl Compounds

2018
Definitive treatment of androgen receptor-positive salivary duct carcinoma with androgen deprivation therapy and external beam radiotherapy.
    Head & neck, 2014, Volume: 36, Issue:1

    Topics: Aged, 80 and over; Androgen Antagonists; Anilides; Biopsy, Needle; Combined Modality Therapy; Female; Follow-Up Studies; Humans; Immunohistochemistry; Leuprolide; Magnetic Resonance Imaging; Neoplasm Staging; Nitriles; Positron-Emission Tomography; Radiotherapy, Intensity-Modulated; Receptors, Androgen; Salivary Gland Neoplasms; Tosyl Compounds; Treatment Outcome

2014
Activity of abiraterone in rechallenging two AR-expressing salivary gland adenocarcinomas, resistant to androgen-deprivation therapy.
    Cancer biology & therapy, 2014, Jun-01, Volume: 15, Issue:6

    Topics: Adenocarcinoma; Adult; Androgen Antagonists; Androstenes; Androstenols; Anilides; Antineoplastic Agents, Hormonal; Drug Resistance, Neoplasm; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasms, Hormone-Dependent; Nitriles; Receptors, Androgen; Salivary Gland Neoplasms; Tosyl Compounds; Treatment Outcome; Triptorelin Pamoate

2014
Clinical activity of androgen deprivation therapy in patients with metastatic/relapsed androgen receptor-positive salivary gland cancers.
    Head & neck, 2016, Volume: 38, Issue:5

    Topics: Adult; Aged; Androgen Antagonists; Anilides; Biomarkers; DNA Mutational Analysis; ErbB Receptors; Female; Humans; Immunohistochemistry; In Situ Hybridization, Fluorescence; Male; Middle Aged; Neoplasm Recurrence, Local; Nitriles; Receptors, Androgen; Retrospective Studies; Salivary Gland Neoplasms; Survival Analysis; Tosyl Compounds; Treatment Outcome; Triptorelin Pamoate

2016
Androgen receptor-positive salivary duct carcinoma: a disease entity with promising new treatment options.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2011, Jun-01, Volume: 29, Issue:16

    Topics: Anilides; Antineoplastic Agents; Bone Neoplasms; Brain Neoplasms; Carcinoma, Ductal; Humans; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Nitriles; Receptors, Androgen; Salivary Ducts; Salivary Gland Neoplasms; Tosyl Compounds

2011